Latest Raising News

Page 17 of 1424
Neuren has lifted its 2026 trofinetide income guidance to US$91 million-US$93 million after Acadia reported a 39% rise in Q3 DAYBUE sales and a US$35 million German launch milestone. Japan trial results also support a planned 2027 regulatory filing, although a launch remains subject to approval and a distribution partner.
Victor Sage
Victor Sage
5 Nov 2026
Northstone Resources has secured an oversubscribed $2.37 million placement as its shares return to trading, funding a run of technical and drilling milestones in Serbia. The raise puts a maiden JORC resource estimate for the Tlamino gold-silver project in sharper focus, while also adding substantial option exposure to the capital structure.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Cyprium Metals has issued 61.35 million shares in the first tranche of its A$20.7 million placement, securing the bulk of the proposed equity funding. A further 1.42 million shares for directors remains conditional on shareholder approval in December.
Maxwell Dee
Maxwell Dee
5 Nov 2026
WEC Energy Group has established a framework to sell up to US$4 billion of common stock, including through forward transactions. No shares have been sold under the agreement yet, leaving the timing, proceeds and potential dilution unresolved.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Oracle has completed a sizeable capital raising combining US$10 billion of notes with the issue of 86.2 million common shares. The company has not yet specified how the proceeds will be divided between investment, debt repayment, acquisitions, dividends or buybacks.
Sophie Babbage
Sophie Babbage
5 Nov 2026
Atmos Energy has forecast higher fiscal 2027 earnings, a larger capital programme and a 9% increase in its annual dividend. The natural gas distributor will also combine its chair and chief executive roles after Kim Cocklin’s retirement.
Maxwell Dee
Maxwell Dee
5 Nov 2026
STERIS delivered 9% second-quarter revenue growth and lifted its fiscal 2027 adjusted EPS outlook, helped partly by tariff refunds. Life Sciences led the operating gains, while weaker cash flow and a new restructuring plan add important qualifications.
Ada Torres
Ada Torres
5 Nov 2026
APA has lifted its 2026 free cash flow outlook by US$600 million to approximately US$2.9 billion, while setting a lower US$2 billion net debt target. Strong Permian production and debt reduction give the oil and gas producer more room for buybacks, dividends and its next investment cycle.
Victor Sage
Victor Sage
5 Nov 2026
Host Hotels delivered an 8.8% rise in comparable hotel RevPAR and lifted its 2026 growth targets, despite a sharp quarterly fall in GAAP net income. Two acquisitions and a cheaper, longer-dated credit facility add a second layer to the lodging REIT’s expansion story.
Eva Park
Eva Park
5 Nov 2026
Canterbury Resources has opened a non-underwritten share purchase plan targeting approximately A$1 million for drilling at its John Hill copper-molybdenum deposit. The company may accept up to A$2.5 million, while all five directors have indicated they intend to participate.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Edwards Lifesciences delivered stronger-than-expected third-quarter growth and lifted its full-year 2026 outlook, led by a sharp rise in mitral and tricuspid therapies. A US$220.2 million impairment charge remains a notable counterpoint to the upbeat operating performance.
Ada Torres
Ada Torres
5 Nov 2026
Eversource Energy narrowed its 2026 recurring earnings guidance after third-quarter GAAP profit fell, while a $26.5 billion investment plan and unresolved regulatory exposures shape the utility’s next phase. The guidance midpoint rose to US$4.66 per share despite lower year-to-date reported earnings.
Maxwell Dee
Maxwell Dee
5 Nov 2026

Browse the archive

Full archive